» Articles » PMID: 36009429

Rapid and Efficient Extraction of Cell-Free DNA Using Homobifunctional Crosslinkers

Overview
Journal Biomedicines
Date 2022 Aug 26
PMID 36009429
Authors
Affiliations
Soon will be listed here.
Abstract

Since its discovery in circulating blood seven decades ago, cell-free DNA (cfDNA) has become a highly focused subject in cancer management using liquid biopsy. Despite its clinical utility, the extraction of cfDNA from blood has many technical difficulties, including a low efficiency of recovery and long processing times. We introduced a magnetic bead-based cfDNA extraction method using homobifunctional crosslinkers, including dimethyl suberimidate dihydrochloride (DMS). Owing to its bifunctional nature, DMS can bind to DNA through either covalent or electrostatic bonding. By adopting amine-conjugated magnetic beads, DMS-DNA complexes can be rapidly isolated from blood plasma. Using standard washing and eluting processes, we successfully extracted cfDNA from plasma within 10 min. This method yielded a 56% higher extraction efficiency than that of a commercial product (QIAamp kit). Furthermore, the instant binding mechanism of amine coupling between the microbeads and DMS-DNA complexes significantly reduced the processing time. These results highlight the potential of this magnetic bead-based homobifunctional crosslinker platform for extraction of cfDNA from blood plasma.

Citing Articles

pH-Sensitive oligopeptide magnetic mesoporous silica beads for deoxyribonucleic acid extraction.

Qian S, Wang Y, Fan J, Kong T, Wang Y, Wang K Nanoscale Adv. 2025; 7(6):1663-1670.

PMID: 39898280 PMC: 11780327. DOI: 10.1039/d4na00987h.


The expansion of liquid biopsies to vascular care: an overview of existing principles, techniques and potential applications to vascular malformation diagnostics.

Mansur A, Radovanovic I Front Genet. 2024; 15:1348096.

PMID: 38304336 PMC: 10832994. DOI: 10.3389/fgene.2024.1348096.


Chemical Trends in Sample Preparation for Nucleic Acid Amplification Testing (NAAT): A Review.

Lee S, Kalathil Balakrishnan H, Doeven E, Yuan D, Guijt R Biosensors (Basel). 2023; 13(11).

PMID: 37998155 PMC: 10669371. DOI: 10.3390/bios13110980.

References
1.
Shapiro B, Chakrabarty M, COHN E, Leon S . Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer. 1983; 51(11):2116-20. DOI: 10.1002/1097-0142(19830601)51:11<2116::aid-cncr2820511127>3.0.co;2-s. View

2.
Kim H, Shin S . ExoCAS-2: Rapid and Pure Isolation of Exosomes by Anionic Exchange Using Magnetic Beads. Biomedicines. 2021; 9(1). PMC: 7824726. DOI: 10.3390/biomedicines9010028. View

3.
Rainer T, Wong L, Lam W, Yuen E, Lam N, Metreweli C . Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem. 2003; 49(4):562-9. DOI: 10.1373/49.4.562. View

4.
Fleischhacker M, Schmidt B . Circulating nucleic acids (CNAs) and cancer--a survey. Biochim Biophys Acta. 2006; 1775(1):181-232. DOI: 10.1016/j.bbcan.2006.10.001. View

5.
Yao W, Mei C, Nan X, Hui L . Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study. Gene. 2016; 590(1):142-8. DOI: 10.1016/j.gene.2016.06.033. View